Important info about cancer drugs not often communicated well to patients: study

Researchers found that information on drug benefits was not reported in any patient leaflets. — Filepic

Important information about cancer drug benefits, and related uncertainties, is frequently omitted from official prescription drug information sources for clinicians and patients in Europe, finds an analysis published by The BMJ.

Despite the commitment of medicines regulators to shared decision making and person-centred care, the researchers say better information on the benefits and potential harms of medicines are needed to help inform treatment decisions, especially for patients with time limiting conditions such as advanced cancer.